News

Featured News

  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | October 9, 2020

    Geeta Vemuri named Top 100 Powerful Women of 2020 by Entrepreneur

    Read More

    News | October 1, 2020

    Skyhawk Therapeutics Named Top 11 Biotech Startup 2020 by Endpoints News

    Read More

    Press Release | September 17, 2020

    Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors

    Read More

    Press Release | September 10, 2020

    ImCheck Achieves Initial Positive Independent Safety Review and Initiates Next Stage of Phase I/IIa EVICTION Trial for ICT01. Company Receives FDA Approval for US IND

    Read More

    News | August 26, 2020

    Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection

    Read More

    News | August 17, 2020

    BMS Licenses IL-12 from Dragonfly in $475 Million Upfront Deal

    Read More

    News | July 29, 2020

    Women in Bio: Geeta Vemuri Blazes a Trail in Venture Capital

    Read More

    Press Release | July 27, 2020

    CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy

    Read More

    News | July 23, 2020

    Clearing the Hurdles to a Career in Venture Capital; An Interview with Geeta Vemuri

    Read More

    Press Release | July 16, 2020

    Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner

    Read More

    Press Release | July 15, 2020

    Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK

    Read More

    Press Release | July 9, 2020

    ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer

    Read More

    Press Release | July 9, 2020

    Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration

    Read More

    Press Release | July 8, 2020

    Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma

    Read More

    News | July 6, 2020

    Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases

    Read More

    Press Release | July 6, 2020

    Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program

    Read More

    Press Release | June 26, 2020

    Aptinyx to be Added to Russell 2000® Index

    Read More

    Press Release | June 18, 2020

    Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder

    Read More

    News | June 3, 2020

    Biotech Pliant Therapeutics pulls off $144M IPO to advance fibrosis pipeline

    Read More

    Press Release | May 28, 2020

    Palvella Therapeutics Completes $45 Million Series C Financing

    Read More